Global Alpha1-Proteinase Inhibitor Market By Product Type (Powder, Liquid) And By End-Users/Application (Hospital, Clinic) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

  • AMR-1037688
  • May 2021
  • Materials and Chemicals
  • 111 Pages
The Alpha1-Proteinase Inhibitor market research report provides an in-depth analysis of the currents trends, latest developments, scenario, market size, various drivers, restraints, and major players along with their profile details. Research report offers the historic data for year 2018 and 2019 and also provides the forecast data from year 2020 to 2028 which is based on revenue (USD Million). With the help of all these information research report helps the market participants to improve market positions. With the help of all these insights Alpha1-Proteinase Inhibitor market research report recommends a business strategy for present market participants to strengthen their position in the market.

According to the report, the Alpha1-Proteinase Inhibitor market size was USD xx million and it is expected to reach USD xx million by the end of 2028, with a CAGR of xx% during 2020-2028. While considering the volume shipments the global Alpha1-Proteinase Inhibitor market stood at xx (Units/Tons) in 2020 and expected to cross near about xx (units/Tons) by the end of forecast period.

Furthermore, the research report includes the detailed information about major players and provides the data regarding the current market scenario as well as upcoming market opportunities or challenges. Similarly, in segment report covers the types, and applications according to the countries and key regions. The research report consists the various drivers and restraints for Alpha1-Proteinase Inhibitor market along with their effects over the forecast period. Similarly, according to the region Alpha1-Proteinase Inhibitor market research report includes the study of opportunities available in the market situation.

The Alpha1-Proteinase Inhibitor market research report provides the in-depth data analysis by using the various graphs, figures, charts, and tables. Furthermore, the report provides the different business challenges which are impacting market growth in all direction.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2019
Forecast Period Covered 2019 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Product Type Powder, Liquid
Applications Hospital, Clinic
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Companies Covered Baxter, Kamada, Talecris Biotherapeutics, Aventis, CSL Behring, Grifols

Global Alpha1-Proteinase Inhibitor Market Segmentation by Regions:
In regional analysis, Alpha1-Proteinase Inhibitor market research report provides the detailed analysis from various regions and also contains the detailed analysis of country. Along with market revenue, market value report also offers the forecast analysis for the following countries and regions. Global Alpha1-Proteinase Inhibitor market report covers the various geographical regions such as North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. Also, various countries included are Canada, U.K., France, the U.S., Japan, China, India, and Germany and so on.

North America Region for Alpha1-Proteinase Inhibitor Market: Value and Forecast
  • U.S.
  • Canada
 
Europe Region for Alpha1-Proteinase Inhibitor Market: Value and Forecast
  • UK
  • Germany
  • France
  • Rest of the Europe
 
Asia Pacific Region for Alpha1-Proteinase Inhibitor Market: Value and Forecast
  • China
  • Japan
  • India
  • Rest of the Asia Pacific
 
Latin America Region for Alpha1-Proteinase Inhibitor Market: Value and Forecast
  • Mexico
  • Brazil
  • Rest of the Latin America
 
Middle East and Africa for Alpha1-Proteinase Inhibitor Market: Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa



Global Alpha1-Proteinase Inhibitor Market Segmentation by Type:
On the basis of product type, global Alpha1-Proteinase Inhibitor market research report provides the production, revenue, price, and market share and growth rate of each type, primarily split into: Powder, Liquid

Global Alpha1-Proteinase Inhibitor Market Segmentation by Applications:
On the basis of the end users/applications, Alpha1-Proteinase Inhibitor research report analyze the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including: Hospital, Clinic

Major Key Players for Global Alpha1-Proteinase Inhibitor Market:
The Alpha1-Proteinase Inhibitor market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Baxter, Kamada, Talecris Biotherapeutics, Aventis, CSL Behring, Grifols

Important Points Covered by Report:
  • To analyze the value of the Alpha1-Proteinase Inhibitor market, according to the key region.
  • To study the Alpha1-Proteinase Inhibitor market current trends, prospects and also their participation in the entire sector.
  • Report consists the in-depth information related to the region/countries, major key players, current trends and their analysis, product type, applications, and other background information
  • Report provides the detailed information about drivers, restraints and future scope of Alpha1-Proteinase Inhibitor market.
  • Report covers the information about historic data analysis as well as forecast period analysis.

Global Alpha1-Proteinase Inhibitor research report consist the information about overall sales and revenue during the historic and forecasted period of 2018 to 2028. Additionally, this report covers the inside and out factual examination and the market elements and requests which give an entire situation of the business.

Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Alpha1-Proteinase Inhibitor market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Alpha1-Proteinase Inhibitor market for numerous purposes such as:

    1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Alpha1-Proteinase Inhibitor market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Alpha1-Proteinase Inhibitor market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Alpha1-Proteinase Inhibitor market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global Alpha1-Proteinase Inhibitor Market Snapshot
          2.1.1. Global Alpha1-Proteinase Inhibitor Market By Type,2019
               2.1.1.1.Powder
               2.1.1.2.Liquid
          2.1.2. Global Alpha1-Proteinase Inhibitor Market By Application,2019
               2.1.2.1.Hospital
               2.1.2.2.Clinic
          2.1.3. Global Alpha1-Proteinase Inhibitor Market By End-use,2019
          2.1.4. Global Alpha1-Proteinase Inhibitor Market By Geography,2019

3. Global Alpha1-Proteinase Inhibitor Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Alpha1-Proteinase Inhibitor Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Alpha1-Proteinase Inhibitor Market Size (US$), By Type, 2018 – 2028

5. Global Alpha1-Proteinase Inhibitor Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Alpha1-Proteinase Inhibitor Market Size (US$), By Application, 2018 – 2028

6. Global Alpha1-Proteinase Inhibitor Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Alpha1-Proteinase Inhibitor Market Size (US$), By End-use, 2018 – 2028

7. Global Alpha1-Proteinase Inhibitor Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Alpha1-Proteinase Inhibitor Market Analysis, 2018 – 2028 
          7.2.1. North America Alpha1-Proteinase Inhibitor Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Alpha1-Proteinase Inhibitor Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Alpha1-Proteinase Inhibitor Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Alpha1-Proteinase Inhibitor Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Alpha1-Proteinase Inhibitor Market Analysis, 2018 – 2028 
          7.3.1.  Europe Alpha1-Proteinase Inhibitor Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Alpha1-Proteinase Inhibitor Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Alpha1-Proteinase Inhibitor Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Alpha1-Proteinase Inhibitor Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Alpha1-Proteinase Inhibitor Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Alpha1-Proteinase Inhibitor Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Alpha1-Proteinase Inhibitor Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Alpha1-Proteinase Inhibitor Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Alpha1-Proteinase Inhibitor Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Alpha1-Proteinase Inhibitor Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Alpha1-Proteinase Inhibitor Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Alpha1-Proteinase Inhibitor Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Alpha1-Proteinase Inhibitor Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Alpha1-Proteinase Inhibitor Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Alpha1-Proteinase Inhibitor Market Analysis, 2018 – 2028 
          7.6.1.  MEA Alpha1-Proteinase Inhibitor Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Alpha1-Proteinase Inhibitor Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Alpha1-Proteinase Inhibitor Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Alpha1-Proteinase Inhibitor Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Alpha1-Proteinase Inhibitor Providers
        8.4.1 Baxter
                8.4.1.1 Business Description
                8.4.1.2 Baxter Geographic Operations
                8.4.1.3 Baxter Financial Information
                8.4.1.4 Baxter Product Positions/Portfolio
                8.4.1.5 Baxter Key Developments
        8.4.2 Kamada
                8.4.2.1 Business Description
                8.4.2.2 Kamada Geographic Operations
                8.4.2.3 Kamada Financial Information
                8.4.2.4 Kamada Product Positions/Portfolio
                8.4.2.5 Kamada Key Developments
        8.4.3 Talecris Biotherapeutics
                8.4.3.1 Business Description
                8.4.3.2 Talecris Biotherapeutics Geographic Operations
                8.4.3.3 Talecris Biotherapeutics Financial Information
                8.4.3.4 Talecris Biotherapeutics Product Positions/Portfolio
                8.4.3.5 Talecris Biotherapeutics Key Developments
        8.4.4 Aventis
                8.4.4.1 Business Description
                8.4.4.2 Aventis Geographic Operations
                8.4.4.3 Aventis Financial Information
                8.4.4.4 Aventis Product Positions/Portfolio
                8.4.4.5 Aventis Key Developments
        8.4.5 CSL Behring
                8.4.5.1 Business Description
                8.4.5.2 CSL Behring Geographic Operations
                8.4.5.3 CSL Behring Financial Information
                8.4.5.4 CSL Behring Product Positions/Portfolio
                8.4.5.5 CSL Behring Key Developments
        8.4.6 Grifols
                8.4.6.1 Business Description
                8.4.6.2 Grifols Geographic Operations
                8.4.6.3 Grifols Financial Information
                8.4.6.4 Grifols Product Positions/Portfolio
                8.4.6.5 Grifols Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Alpha1-Proteinase Inhibitor Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Alpha1-Proteinase Inhibitor Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Alpha1-Proteinase Inhibitor Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Alpha1-Proteinase Inhibitor Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Alpha1-Proteinase Inhibitor Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Alpha1-Proteinase Inhibitor Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Alpha1-Proteinase Inhibitor Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Alpha1-Proteinase Inhibitor Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Alpha1-Proteinase Inhibitor Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Alpha1-Proteinase Inhibitor Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Alpha1-Proteinase Inhibitor Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Alpha1-Proteinase Inhibitor Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Alpha1-Proteinase Inhibitor Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Alpha1-Proteinase Inhibitor Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Alpha1-Proteinase Inhibitor Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Alpha1-Proteinase Inhibitor Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Alpha1-Proteinase Inhibitor: Market Segmentation 
FIG. 2 Global Alpha1-Proteinase Inhibitor Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Alpha1-Proteinase Inhibitor Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Alpha1-Proteinase Inhibitor Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Alpha1-Proteinase Inhibitor Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Alpha1-Proteinase Inhibitor Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Alpha1-Proteinase Inhibitor Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Alpha1-Proteinase Inhibitor Providers, 2019
FIG. 11 Global Alpha1-Proteinase Inhibitor Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Alpha1-Proteinase Inhibitor Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Alpha1-Proteinase Inhibitor Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Alpha1-Proteinase Inhibitor Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Alpha1-Proteinase Inhibitor Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Alpha1-Proteinase Inhibitor Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Alpha1-Proteinase Inhibitor Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Alpha1-Proteinase Inhibitor Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Alpha1-Proteinase Inhibitor market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Alpha1-Proteinase Inhibitor Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Alpha1-Proteinase Inhibitor Market Value, By Segment1, 2018 – 2028
TABLE  North America Alpha1-Proteinase Inhibitor Market Value, By Segment2, 2018 – 2028
TABLE  North America Alpha1-Proteinase Inhibitor Market Value, By Country, 2018 – 2028
TABLE  Europe Alpha1-Proteinase Inhibitor Market Value, By Segment1, 2018 – 2028
TABLE  Europe Alpha1-Proteinase Inhibitor Market Value, By Segment2, 2018 – 2028
TABLE  Europe Alpha1-Proteinase Inhibitor Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Alpha1-Proteinase Inhibitor Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Alpha1-Proteinase Inhibitor Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Alpha1-Proteinase Inhibitor Market Value, By Country, 2018 – 2028
TABLE  Latin America Alpha1-Proteinase Inhibitor Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Alpha1-Proteinase Inhibitor Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Alpha1-Proteinase Inhibitor Market Value, By Country, 2018 – 2028
TABLE  MEA Alpha1-Proteinase Inhibitor Market Value, By Segment1, 2018 – 2028
TABLE  MEA Alpha1-Proteinase Inhibitor Market Value, By Segment2, 2018 – 2028
TABLE  MEA Alpha1-Proteinase Inhibitor Market Value, By Country, 2018 – 2028
TABLE  Baxter: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Kamada: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Talecris Biotherapeutics: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Aventis: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  CSL Behring: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Grifols: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Alpha1-Proteinase Inhibitor Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Alpha1-Proteinase Inhibitor Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Alpha1-Proteinase Inhibitor Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Alpha1-Proteinase Inhibitor Market, By Geography, 2019 (US$ Mn)
FIG.  Global Alpha1-Proteinase Inhibitor Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Alpha1-Proteinase Inhibitor Providers, 2016
FIG.  Global Alpha1-Proteinase Inhibitor Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Powder Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Liquid Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Alpha1-Proteinase Inhibitor Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Hospital Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Clinic Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Alpha1-Proteinase Inhibitor Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Alpha1-Proteinase Inhibitor Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Alpha1-Proteinase Inhibitor Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Alpha1-Proteinase Inhibitor Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Alpha1-Proteinase Inhibitor Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Alpha1-Proteinase Inhibitor Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Alpha1-Proteinase Inhibitor Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Alpha1-Proteinase Inhibitor Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Alpha1-Proteinase Inhibitor Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Alpha1-Proteinase Inhibitor Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Alpha1-Proteinase Inhibitor Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Alpha1-Proteinase Inhibitor Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Alpha1-Proteinase Inhibitor Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Alpha1-Proteinase Inhibitor Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Alpha1-Proteinase Inhibitor Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Alpha1-Proteinase Inhibitor Market Value, 2018 – 2028, (US$ Mn)